Fig. 2From: In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer’s diseaseProportions of in vivo amyloid stages at PET follow-up according to the amyloid stage at baseline. Amyloid stages at follow-up are calculated for the longest available PET follow-up. Participants non-stageable at baseline were excludedBack to article page